by Endobronchial ultrasound biopsies are noninvasive procedures that help physicians visualize and obtain samples from lymph nodes and tissues surrounding the airways and lungs. The procedure utilizes an endoscope fitted with an ultrasound probe at its tip to obtain clear ultrasound images and to guide a biopsy needle to precisely collect tissue samples from targeted areas for examination under a microscope. With timely and accurate diagnoses, endobronchial ultrasound biopsies help doctors formulate the most suitable treatment plans for lung cancer and other respiratory disorders.
The global endobronchial ultrasound biopsy market is gaining traction as noninvasive diagnostic techniques are increasingly preferred over invasive surgical biopsies. With advantages such as real-time imaging, high resolution, minimal risk of complications and good sampling yield, endobronchial ultrasound biopsy has emerged as a popular method to diagnose lung cancer and sarcoidosis. The procedure allows physicians to access lymph nodes beyond the reach of normal bronchoscopy and obtain tissue specimens without radiation exposure. Advancements in endobronchial ultrasound technologies with finer needles and improved imaging capabilities have enhanced the precision and safety of biopsies.
The global Endobronchial Ultrasound Biopsy Market is estimated to be valued at US$ 722.67 Bn in 2023 and is expected to exhibit a CAGR of 7.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends in the endobronchial ultrasound biopsy market is the adoption of AI and digital imaging technologies. Manufacturers are increasingly integrating AI capabilities in endobronchial ultrasound systems to provide automated and real-time image enhancement, tissue characterization, and navigation guidance during biopsies. This helps clinicians obtain better quality images with more detail for accurate diagnosis. Systems powered by AI can also map out the patient’s bronchial tree structure and annotate biopsy sites to facilitate systematic and complete examinations. Advanced digital imaging solutions also allow for multiplanar view options as well as storage and review of high definition ultrasound images and video clips for subsequent reference and consultation. Such technologies are expected to revolutionize endobronchial ultrasound procedures and drive the market growth over the forecast period.
Porter’s Analysis
Threat of new entrants: The high capital requirements and economies of scale of endobronchial ultrasound biopsy procedures pose moderate barriers for new companies entering the market.
Bargaining power of buyers: The need for advanced diagnostic procedures by hospitals and healthcare providers gives buyers some bargaining power in this market.
Bargaining power of suppliers: A few large companies dominate the supply of endobronchial ultrasound biopsy devices, giving them strong bargaining power.
Threat of new substitutes: There are limited existing or potential substitutes for endobronchial ultrasound biopsy procedures that can accurately diagnose lung cancers and other respiratory diseases.
Competitive rivalry: Competition in the endobronchial ultrasound biopsy market is high as the major players try to differentiate their product offerings through innovative features and lower costs.
Key Takeaways
The Global Endobronchial Ultrasound Biopsy Market Size is expected to witness high growth.
Regional analysis comprises North America dominates the global market and is expected to continue its dominance over the forecast period as well. This can be attributed to high healthcare expenditure, availability of advanced healthcare facilities and growing prevalence of cancer in the region. Asia Pacific is expected to witness the highest growth rate during the forecast period owing to increasing healthcare expenditure, improving healthcare infrastructure and growing awareness regarding early cancer detection and diagnosis.
Key players operating in the Endobronchial Ultrasound Biopsy market are Alf Engineering, F-TECH, Magna International, Metalsa, Nissin Kogyo, Sango Co., Ltd., Tata Precision Tubes, Tenneco, Thyssenkrupp AG, Vari-Form, and Yorozu. Key players are focusing on new product launches and geographic expansion to strengthen their market presence. For instance, in 2022, Fujifilm launched its new EBUS-TBNA needle SureAx which introduced a new triangular beam shape for improved tissue sampling.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
